Edward Hurwitz's Trading History
| MGNXMacroGenics | May 20, 2026 | Director | Uninformative Buy | 16.31K | $114.78K | |
| AGTCApplied Genetic Technologies | Dec 01, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| DYNDyne Therapeutics | Sep 23, 2020 | Director | Uninformative Buy | ― | $1.52M | |
| VIRXViracta Therapeutics | Jul 01, 2010 | ― | Uninformative Buy | 3.22M | $3.82K | |
| TVRDTvardi Therapeutics | ― | Director, Ten Percent Owner | ― | $0.00 |
You May Also Like
Edward Hurwitz insider profile FAQ
What is the percentage of profitable transactions made by Edward Hurwitz?
The percentage of profitable transactions made by Edward Hurwitz is 0%.
What is the average return per transaction made by Edward Hurwitz?
The average return per transaction made by Edward Hurwitz is -15.80%.
What stocks does Edward Hurwitz hold?
Edward Hurwitz holds: DYN, MGNX, AGTC, VIRX, TVRD stocks.
What was Edward Hurwitz’s latest transaction?
Edward Hurwitz’s latest transaction was an Uninformative Buy of $16.31K.
What was Edward Hurwitz's most profitable transaction?
Edward Hurwitz’s most profitable transaction was an Informative Sell of MGNX stock on February 18, 2014. The return on the trade was -3.90%.
What is Edward Hurwitz's role in Dyne Therapeutics?
Edward Hurwitz's role in Dyne Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.